A novel osteopontin-like protein is expressed in the trout ovary during ovulation  by Bobe, Julien & Goetz, Frederick William
A novel osteopontin-like protein is expressed in the trout ovary during
ovulation
Julien Bobea, Frederick William Goetzb;*
aInstitut National de la Recherche Agronomique, S.C.R.I.B.E., Campus de Beaulieu, 35042 Rennes Cedex, France
bUniversity of Notre Dame, Department of Biological Sciences, P.O. Box 369, Notre Dame, IN 46556-0369, USA
Received 22 December 2000; accepted 3 January 2001
First published online 15 January 2001
Edited by Veli-Pekka Lehto
Abstract Using suppression subtraction hybridization between
ovulatory and postovulatory trout ovaries, a down-regulated
cDNA was obtained that presumably encodes a novel ovarian
protein (‘NOP’). NOP mRNA is present in the ovary during
ovulation and down-regulated by 48 h postovulation, suggesting
an important role for NOP during ovulation. Besides the ovary,
NOP is also strongly expressed in the testis and at lower levels
in the skin, gills, kidney and gastrointestinal tract. While the
overall identity is not high, NOP shares several sequence
similarities with mammalian and chicken osteopontins, including
the percentage of aspartate, serine and alanine residues and the
presence of a cell attachment motif. ß 2001 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Vertebrate ovulation has been compared to an in£amma-
tory reaction [1]. As such, many factors could potentially be
involved in the control of ovulation. In mammals, the process
of ovulation has been thoroughly studied and many ovarian
factors have been hypothesized to be involved [1]. Given the
large number of potential ovulatory mediators, we have uti-
lized subtractive cloning approaches to isolate transcripts that
change during the periovulatory period. For example, a family
of proteins that are highly up-regulated in the trout ovary at
ovulation and have sequence similarities to serine protease
inhibitors were isolated using conventional cDNA subtraction
[2]. Using di¡erential display PCR, a gastricsin-like protein
was identi¢ed in the brook trout ovary that was highly up-
regulated 4^10 days following ovulation [3].
While these subtractive approaches successfully identi¢ed
gene products regulated during the periovulatory period, a
more inclusive subtraction technique is suppression subtrac-
tion hybridization (SSH). Thus, in order to identify other
factors that could play an important role in the ¢sh ovary
during the ovulatory period, we used SSH between ovulatory
and postovulatory ovarian tissue to look for down-regulated
mRNAs following ovulation in rainbow trout. From this sub-
traction, we obtained two down-regulated cDNAs encoding
proteins present in high quantity in the ovary during ovula-
tion that we previously identi¢ed using other subtraction tech-
niques [2,4]. However, we also obtained a di¡erentially ex-
pressed cDNA presumably encoding a protein with no
signi¢cant similarity when blasted directly against the Gen-
Bank database, that we provisionally call a novel ovarian
protein (NOP). Using an ‘annotation-sorted similarity’ search,
some sequence similarity can be observed between NOP and
several vertebrate osteopontins (OPNs). In the present paper,
we describe this novel mRNA and its expression within the
ovary during the periovulatory period.
2. Materials and methods
2.1. Animal and tissue collection
Investigations and animal care were conducted according to the
guidelines speci¢ed by the University of Notre Dame Institutional
Animal Care and Use Committee.
Mature rainbow trout (Oncorhynchus mykiss) and brook trout (Sal-
velinus fontinalis) were obtained during the reproductive season. Prior
to collecting tissue, the reproductive stage of individual trout was
determined by sampling follicles in vivo as previously described [5].
For both species, ovarian tissue was collected from ovulating females
(20^100% of the ovary ovulated at the time of sampling), and 1, 2, 4^6
and 8^10 days after ovulation for both species. In addition, brook
trout ovarian tissue was collected from females prior to germinal
vesicle breakdown (GVBD). For in vitro incubations with phorbol
esters, ovarian tissue was collected as previously described [6,7]. To
collect ovarian tissue, trout were over-anesthetized in 2-phenoxyetha-
nol and decapitated. The abdominal cavity was opened and the ova-
ries were removed, dissected, and aliquots were stored in liquid nitro-
gen before RNA extraction. In addition, from a female assayed at 48 h
postovulation, di¡erent tissues were removed and aliquots stored in
liquid nitrogen before RNA extraction. Testes were also removed
from a spermiating male and aliquots were stored in liquid nitrogen.
2.2. In vitro incubation for phorbol ester stimulation
Large scale in vitro incubations of phorbol ester-stimulated follicles
were performed as previously described [6,7]. Stimulated follicles re-
ceived a combined treatment of 0.05 Wg phorbol-12-myristate-13-ace-
tate (PMA, Sigma, St. Louis, MO, USA)/ml and 0.05 Wg A23187
(Calbiochem, La Jolla, CA, USA)/ml and separate groups were incu-
bated for 6 or 12 h at 12‡C under intermittent agitation. Following
incubation, the ovarian tissue was processed for RNA as described
below.
2.3. RNA extraction and Poly(A)+ RNA isolation
Total RNA was extracted by homogenization in 1 ml of Tri Re-
agent (Molecular Research Center, Inc., Cincinnati, OH, USA) per
50 mg tissue [8,9]. Poly(A) RNA was isolated using the PolyAtract
mRNA Isolation System (Promega, Madison, WI, USA).
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2.4. SSH and Northern capture
SSH was performed using a kit (PCR Select, Clontech, Palo Alto,
CA, USA) according to the manufacturer’s instructions. Ovarian
mRNA from female rainbow trout sampled at ovulation and 4^
8 days postovulation was used for the subtraction. For each repro-
ductive stage, 0.4 Wg of mRNA from each of ¢ve ¢sh (2.0 Wg total)
was pooled to perform SSH analysis. Brie£y, after reverse transcrip-
tion and second strand synthesis, ovulatory and postovulatory cDNA
was digested with RsaI. An adaptor (adaptor 1) was ligated on both
ends of a fraction of digested cDNA obtained at ovulation. This
fraction was referred to as ‘tester 1’. A di¡erent adaptor (adaptor
2R) was ligated on a second fraction of digested cDNA (referred to
as ‘tester 2’) from the same ovulatory stage. Postovulatory cDNA was
also digested with RsaI and is referred to as the ‘driver’. Initially, two
separate hybridizations were performed at 68‡C for 8 h using an
excess of driver and either tester 1 or 2. These two hybridization
mixtures were then pooled in the presence of an excess of driver
and incubated at 68‡C overnight. After hybridization, the mixture
was diluted and used for PCR. After incubation at 75‡C for 5 min
and 94‡C for 25 s, a primary PCR was performed (94‡C, 10 s; 66‡C,
30 s; 72‡C, 1 min and 30 s; 27 cycles) using Advantage Polymerase
Mix (Clontech) with a primer that was complementary to both adap-
tors 1 and 2R. A secondary PCR was then performed (94‡C, 10 s;
68‡C, 30 s; 72‡C, 1 min and 30 s; 11 cycles) using a diluted aliquot of
the primary PCR as a template, and primers complementary only to
adaptor 1 (primer 1) and only to adaptor 2R (primer 2R). This PCR
was performed in presence of [32P]dATP (ICN, Costa Mesa, CA,
USA). The resulting PCR mixture was then applied to a Centrisep
Column (Princeton Separation, Adelphia, NJ, USA) to remove unin-
corporated reagents. After denaturation, this labeled PCR mixture
was used to probe a Northern blot on which total RNA from di¡erent
females sampled at ovulation and 4^8 days postovulation had been
run in separate lanes. After washing under stringent conditions, the
Northern blot was exposed to X-ray ¢lm for 48 h. The ¢lm and
original Northern membrane were aligned and di¡erentially regulated
bands between ‘ovulation’ and ‘4^8 days postovulation’ females were
excised, soaked in water for 10 min and boiled for at least 10 min.
After spinning, the supernatant was removed and the DNA was etha-
nol-precipitated (370‡C, overnight) in the presence of glycogen using
3 M sodium acetate and absolute ethanol. The samples were centri-
fuged to pellet the DNA and washed. An aliquot of the DNA was
reampli¢ed by PCR (94‡C, 10 s; 68‡C, 30 s; 72‡C, 1 min and 30 s;
30 cycles) using primers 1 and 2R. The reampli¢ed PCR products
were then separated on an agarose gel, the bands were cut and cloned
in TOPO pCR 2.1 (Invitrogen, San Diego, CA, USA) and the ligated
plasmid was used to transform competent TOP 10 cells (Invitrogen).
Inserts were sequenced as previously described [6] and were used to
probe Northerns to substantiate that the band truly represented a
di¡erentially regulated cDNA as observed during the original North-
ern capture.
2.5. Cloning of full-length cDNA
Ovulatory rainbow and brook trout phorbol ester-stimulated
cDNA libraries were constructed in ZAP Express (Stratagene, La
Jolla, CA, USA). The rainbow trout library was screened under
high stringency as previously described [6], using the cDNA band
obtained from Northern capture. A number of positive plaques
were obtained, rescreened once to homogenity, converted to pBK-
CMV (Stratagene) phagemids by in vivo excision, and the phagemids
were used to transfect XLOLR cells. Six clones were obtained and two
of the largest were sequenced on both strands as previously described
[6].
From the rainbow trout full-length cDNA, two primers were de-
signed to amplify a 550 bp fragment using the brook trout cDNA
library as a template. This band was cloned, sequenced and used to
screen the brook trout library as described above. Five clones were
obtained and three of the largest were sequenced on both strands as
previously described [10].
2.6. Northern blot analysis
Northern blot analysis was performed using mRNA from brook
trout tissue as previously described [6]. Brightstar nylon membranes
(Ambion, Austin, TX, USA) were hybridized overnight at 42‡C in
ULTRAhyb bu¡er (Ambion). All Northerns were probed using the
full-length brook trout NOP (btNOP) cDNA (accession # AF223388)
obtained from library screening, and were washed under stringent
conditions (15 min twice in 1U SSPE, 0.1% sodium dodecyl sulfate
(SDS), 45‡C and 15 min twice in 0.1U SSPE, 0.5% SDS, 65‡C).
Northern blots were exposed to phosphorimaging screens (Kodak,
Rochester, NY, USA) and visualized using a Storm 840 phosphorim-
ager (Molecular Dynamics, Sunnyvale, CA, USA). When necessary,
radioactive RNA bands were quanti¢ed using Imagequant (Molecular
Dynamics) and the results were analyzed statistically using an
ANOVA followed by Tukey’s test to evaluate signi¢cant di¡erences
in mRNA levels between reproductive stages.
2.7. Expression of btNOP recombinant fusion protein for antibody
production
The presumed btNOP (accession # AF223388) open reading frame
was ampli¢ed by PCR. This fragment was cloned into the pMAL-c2E
(New England Biolabs, Beverly, MA, USA) expression vector as pre-
viously described [3] and used to transform competent Escherichia coli
INVKFP cells (Invitrogen). One of the clones was sequenced and
found to contain no PCR artifacts. Expression in this system produces
a fusion protein consisting of maltose binding protein (MBP) and the
trout NOP protein separated by an enterokinase cleavage site.
A fusion protein was produced and puri¢ed using an amylose af-
¢nity column as previously described [4]. A fraction with the highest
protein content and the least amount of contaminating protein was
chosen for immunization.
2.8. Antibody production and puri¢cation
Rabbits were immunized subcutaneously with 500 Wg of puri¢ed
fusion protein mixed with Freund’s complete adjuvant. Booster injec-
tions consisting of 500 Wg of puri¢ed fusion protein mixed with
Freund’s incomplete adjuvant were given on days 14, 28 and 42.
Immune serum was collected after exsanguination on day 52.
IgGs were puri¢ed from the immune serum and antibodies to MBP
and copuri¢ed E. coli proteins were removed as previously described
[4].
2.9. Immunocytochemistry
Ovarian tissues obtained from female brook trout sampled during
ovulation and 5^8 days postovulation were ¢xed and embedded in
para⁄n as previously described [11]. Tissue sections (8 Wm) were cut
and placed on silane-treated microscope slides (Polysciences, Warring-
ton, PA, USA).
Immunocytochemistry was performed using the ABC Staining Sys-
tem (Santa Cruz Biotechnology, Santa Cruz, CA, USA) according to
the manufacturer’s instructions as described before [3]. Primary anti-
body was diluted in blocking serum (10 Wg/ml) and applied overnight
at 4‡C. To validate the speci¢city of the signal, adjacent sections were
either incubated in the absence of the primary antibody or incubated
with an antibody directed against an ovarian progastricsin [3] at the
same dilution. The progastricsin antibody was also directed against a
MBP fusion and produced using the same protocol. This antibody
gives a speci¢c signal on ovarian sections from 5 to 8 days postovu-
lation but not during ovulation [3].
Adjacent sections were cleared in toluene, hydrated in decreasing
ethanolic solutions and stained in hematoxylin and counterstained in
eosin as previously described [11].
3. Results
3.1. SSH and Northern capture
From SSH and Northern capture, three down-regulated
cDNAs were obtained. One of these cDNAs was a trout ovu-
latory protein (‘TOP’) mRNA which is known to be present in
high quantity in the brook trout ovary and down-regulated
after ovulation [2]. The second cDNA was a trout kallikrein-
like mRNA that is also present in the ovary and is down-
regulated in the postovulatory ovary [4].
A third down-regulated cDNA was obtained that had not
been previously identi¢ed and was used to screen a rainbow
trout cDNA library made from ovaries taken at the time of
ovulation. The full-length cDNA obtained from this library
screen presumably encodes a protein that has little or no
homology to known proteins when directly blasted in Gen-
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Bank. Therefore, this protein was provisionally called
‘NOP’.
3.2. Brook and rainbow trout NOP cDNA and protein
sequence
The full-length rtNOP cDNA (AF204760) obtained from
library screening is 1545 bp in length. An ATG site is present
at position 131 with an in-frame stop codon at position 1174.
The ACAATGA sequence surrounding the start site between
positions 128 and 134 resembles the preferred eukaryotic ini-
tiation sequence of ACCATGG [12]. The open reading frame
presumably encodes a 347 amino acid protein with a calcu-
lated molecular mass of 36.0 kDa (Fig. 1).
The full-length btNOP cDNA (AF223388) obtained from
library screening is 1568 bp in length. An ATG site was
present at position 136 with an in-frame stop codon at posi-
tion 1215. The ACAATGA sequence surrounding the start
site between positions 133 and 139 resembles the preferred
eukaryotic initiation sequence of ACCATGG [12]. The open
reading frame presumably encodes a 359 amino acid protein
with a calculated molecular mass of 37.3 kDa (Fig. 1). Over-
all, the nucleotide sequences of the two NOP cDNAs are
highly similar (over 90%). However, the coding region of
the btNOP is longer than rtNOP because of a single 12 amino
acid addition in btNOP at amino acid 96 (Fig. 1).
The putative amino acid sequences of btNOP and rtNOP
are extremely similar and are characterized by the presence of
a high number of serine residues (16^17%) and the absence of
cysteine and tryptophan residues. The btNOP and rtNOP
amino acid sequences are also rich in alanine (11^12%), as-
partic acid (11%), threonine (10%) and glutamic acid (10%).
In addition, both rtNOP and btNOP contain a G-R-G-D-S
motif identi¢ed as a cell attachment motif (Fig. 1).
While no signi¢cant sequence similarities were observed by
directly blasting the rtNOP or btNOP sequences in GenBank,
an ‘annotation-sorted similarity’ search on the Protein Infor-
mation Resource website (http://pir.georgetown.edu) indi-
cated some sequence similarities between NOP and several
OPNs (20^25% identity) (Fig. 1).
Fig. 1. Amino acid sequence alignment of brook trout (b trout; accession # AF223388) and rainbow trout (r trout; accession # AF204760)
NOPs, and human (accession # X13694), mouse (accession # J04806) and chicken (accession # X56772) OPNs.
Fig. 2. (A) Northern blot of mRNA (0.5 Wg/lane) from ovarian tis-
sue of females sampled before GVBD (preGVBD), during ovulation
(OV) and at various times postovulation: within 12 h (6 12 h), 48 h
(48 h), 6^8 days (6^8 d). Each lane represents mRNA from a di¡er-
ent female. (B) Graph representing the average intensity ( þ S.D.) of
the 1.6 kb NOP transcript analyzed over the di¡erent reproductive
stages using the results from the females shown in ‘A’. *Signi¢cantly
di¡erent from ovulation at P6 0.05.
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3.3. Northern blots probed with btNOP cDNA
On Northern blots, the full-length btNOP cDNA hybrid-
ized predominantly with a 1.6 kb transcript (Figs. 2^4). The
NOP mRNA was detected in the ovary before and during
ovulation and the highest levels of expression were observed
in females at the completion of ovulation. The mRNA was
signi¢cantly down-regulated in the ovary 48 h postovulation
and decreased even further by 5^8 days postovulation (Fig. 2).
On Northern blots of mRNA from other tissues, the NOP
mRNA was strongly detected in the testis and the ovulatory
ovary (Fig. 3). In addition, it was also detected at low levels in
several other tissues such as the kidney, gills and skin (Fig. 3).
The size of the transcripts detected in all tissues appeared to
be identical. On a Northern blot of PMA/A23187-stimulated
follicles, btNOP mRNA was up-regulated in some females
after 6 h. In contrast, after 12 h of in vitro incubation, a
strong up-regulation was observed (Fig. 4). Interestingly, a
higher size transcript was present in 12 h phorbol ester-stimu-
lated samples.
3.4. Immunolocalization of NOP proteins in the brook trout
ovulatory follicle
Ovarian sections from females sampled during ovulation
were stained with hematoxylin and eosin. These sections
clearly show distinct granulosa and theca layers in the follicles
(Fig. 5). Prior to ovulation, the theca and granulosa layers in
trout follicles are stretched to accommodate a large (V4 mm)
oocyte. However, after ovulation the follicle shrinks dramat-
ically and the granulosa then appears multilayered. Using
immunocytochemistry, the NOP antibody produced a strong
signal in many of the granulosa cells of ovulatory follicles
(Fig. 5). In contrast, no signal was observed using the progas-
tricsin control antibody.
The NOP antibody did not recognize any bands on Western
blots of protein taken from ovaries throughout the periovu-
latory period.
4. Discussion
While a direct ‘Blast’ search against GenBank using the
amino acid sequence of btNOP and rtNOP showed little ho-
mology with known proteins, an annotation-sorted similarity
search detected sequence similarities between NOP and OPNs.
When fully aligned, the overall identity between NOP and
OPNs is not particularly strong at the amino acid level (20^
25%, Fig. 1). However, the primary amino acid sequences of
NOPs and OPNs share several common characteristics. For
example, OPNs are rich in aspartic acid, glutamic acid and
serine, similar to the percentage of these residues in the NOP
sequences. OPNs contain a cell attachment motif (G-R-G-D-
S) that is also present in NOP. Furthermore, OPNs contain an
aspartic acid-rich domain up-stream of the cell attachment
motif. In NOP, the region up-stream of the G-R-G-D-S do-
main is also rich in aspartic acid residues and the sizes of
rtNOP (347 aa) and btNOP (359 aa) are close to the size of
OPNs (V300 aa). The low identity between the amino acid
sequences of OPN and NOP is consistent with the low iden-
tities observed between murine and other vertebrate OPNs
(human, 50%; chicken, 29%).
NOP mRNA is detected in the ovary before GVBD and
high levels of NOP mRNA are observed in the ovary during
ovulation in all females assayed. The highest levels were ob-
served in females within 24 h of ovulation. However, at this
stage, half of the females had levels similar to those observed
by 48 h postovulation. This suggests that levels of NOP
mRNA peak immediately at the end of ovulation and then
rapidly decrease. By 48 h postovulation, levels of NOP tran-
scripts are signi¢cantly lower than during ovulation and are
even lower by 5^8 days postovulation. The pattern of expres-
sion of the NOP cDNA in the periovulatory ovary strongly
suggests that NOP could play a role in ovulation in salmo-
nids. This hypothesis is also supported by the strong up-reg-
ulation of NOP by phorbol ester after 12 h of in vitro stim-
ulation. The exogenous activation of protein kinase C by
phorbol esters has an e¡ect on several ovarian processes in
¢sh involved in ovulation, including oocyte expulsion [13,14]
and prostaglandin synthesis [15]. The up-regulation of NOP
by phorbol ester is also consistent with an increase in OPN
mRNA levels observed in mice after stimulation by phorbol
esters [16].
Immunostaining of NOP proteins was clearly obtained on
ovarian sections within the granulosa cells of the follicle.
Fig. 4. Northern blot of mRNA (0.5 Wg/lane) from ovarian follicles
of six di¡erent females in the presence of dimethylsulfoxide vehicle
(C) or treated (P) for 12 (A) and 6 (B) h in vitro with a combina-
tion of PMA and A23187. Graph (C) represents the average inten-
sity ( þ S.D.) for control (C) and PMA/A23187 treatment (P) after
6 and 12 h of incubation. *Signi¢cantly di¡erent from control at
P6 0.05.
Fig. 3. Northern blot of mRNA (0.5 Wg per lane) from di¡erent tis-
sues sampled from a postovulatory female 48 h after ovulation and
a testis from a spermiating male. The right lane contains mRNA
from an ovary during ovulation.
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However, we were unable to observe NOP immunostaining on
Western blots of ovarian tissue and coelomic £uid using the
same antibody. During the extraction of tissues for Western
analysis, it is possible that conformational changes occurred
in the protein that made the antibody unable to detect NOP
on Western blots. Interestingly, Cancel and coworkers [17]
failed to immunodetect OPN in the bull reproductive tract
and suggested that posttranslational modi¢cations might
have compromised the ability of the OPN antibody to detect
OPN in these tissues.
The NOP transcript was predominantly detected in the ova-
ry and the testis suggesting a role in gonadal function. How-
ever, a signal was observed in several other tissues such as the
skin, kidney, gills, intestine, stomach, spleen and brain. The
tissue distribution of btNOP is also consistent with the tissue
distribution of OPNs. OPN mRNA has been reported in
mammalian bone cells, cartilage, fetal skin, brain, kidney,
ovary, uterus and other tissues [18^22]. In addition, OPN
mRNA and protein were detected in mouse testis and sperm
[23].
Thus, while the exact identity of NOP is unknown, several
characteristics of the sequence and expression suggest that it
could be related to OPN. OPN is a multifunctional glycopro-
tein that promotes cell adhesion and migration [24]. Previous
studies have suggested that OPN plays a role in bone resorp-
tion, tumorigenesis and metastasis. More recently, OPN has
been implicated in a number of disease states associated with
in£ammation and tissue remodeling. Several functional fea-
tures of OPNs are consistent with the presence of NOP in
the ovary during and immediately following ovulation. For
example, vertebrate ovulation has often been compared with
an in£ammatory reaction [1]. Interestingly, OPN can stimu-
late macrophages invasion [25] and T-cell activation [26] and
recruitment [27]. Finally, the immunolocalization of NOP to
cells in the granulosa layer that is con£uent with the coelomic
£uid is consistent with the presence of OPNs on many epithe-
lial surfaces communicating with the external environment
[28].
In conclusion, a novel ovarian protein was identi¢ed by
SSH in trout. This protein shows sequence similarities with
OPN suggesting that NOP could be the trout homolog of
OPN. Furthermore, the temporal expression of the NOP
mRNA suggests that NOP could play an important role in
the ovary during the periovulatory period in ¢sh.
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